Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06813742

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

Sponsor: First Affiliated Hospital of Zhejiang University

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with pheochromocytoma.

Official title: A Prospective Exploratory Study Evaluating the Diagnostic Usefulness of 18F-mFBG PET Imaging in Pheochromocytoma

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2023-05-01

Completion Date

2026-12

Last Updated

2025-08-07

Healthy Volunteers

No

Interventions

DRUG

18F-MFBG

Patients with pheochromocytoma malignancies receive 5.55 MBq/kg of 18F-MFBG intravenously followed by PET/CT or PET/MR after 60min of injection.

Locations (2)

The First Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

The First Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China